LIVN
LivaNova Plc
NASDAQ · Healthcare · Medical - Devices · GB
$90.41
−0.81%Price chart
Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3Nov 6
Key dataNov 6, 2026
Open$90.09
From 52W high−4.02%
Volume26992.00
Market cap$4.98B
P/E (TTM)25.3x
P/S (TTM)3.3x
Div yield—
Key dataNov 6, 2026
Open
$90.09
From 52W high
−4.02%
Volume
26992.00
Market cap
$4.98B
ValuationView details →
P/E (Fwd)
20.0x
EV/EBITDA
22.5x
P/E (TTM)
25.3x
RSI (14)
70.5
MomentumView details →
1D Return
−0.81%
YTD Return
+48.52%
SummaryUpdated Sep 1, 2026
LivaNova PLC (NASDAQ:LIVN) is a medical device company founded in 1987 and headquartered in London, United Kingdom. The company was created through the 2015 merger of Cyberonics and Sorin Group, combining expertise in neuromodulation and cardiac surgery technologies. LivaNova designs, develops, manufactures, and sells therapeutic solutions globally, focusing on three core segments: cardiopulmonary products for heart surgery, neuromodulation devices for neurological conditions, and advanced circulatory support systems. The company serves hospitals, medical institutions, and healthcare providers worldwide through direct sales representatives and independent distributors.
Similar companies
Latest newsMore news →
LivaNova PLC reported quarterly earnings of $1.23 per share, compared with $1.11 per share a year earlier.2d agoLivaNova reported third-quarter 2026 revenue of $393.1 million, up 9.9% reported and 10.0% at constant currency year over year, and GAAP diluted EPS of $0.11.2d agoLivaNova announced publication of the full 36-month LivaNova PLC results evaluating its VNS Therapy devices in people with drug-resistant epilepsy.14d ago